Inter-individual variation in morphine clearance in children

Abstract

ObjectivesThe aim of the study was to determine the extent of inter-individual variation in clearance of intravenous morphine in children and to establish which factors are responsible for this variation.MethodsA systematic literature review was performed to identify papers describing the clearance of morphine in children. The following databases were searched: Medline, Embase, International Pharmaceutical Abstracts, CINAHL, and Cochrane library. From the papers, the range in plasma clearance and the coefficient of variation (CV) in plasma clearance were determined.ResultsTwenty-eight studies were identified. After quality assessment, 20 studies were included. Only 10 studies gave clearance values for individual patients. The majority of the studies were in critically ill patients. Inter-individual variability of morphine clearance was observed in all age groups, but greatest in critically ill neonates (both preterm and term) and infants. In critically ill patients, the CV was 16–9 7 % in preterm neonates, 24–87 % in term neonates, 35 and 134 % in infants, 39 and 55 % in children, and 74 % in adolescents. The CV was 37 and 44 % respectively in non-critically ill neonates and infants. The mean clearance was higher in children (32 and 52 ml min-1 kg-1) than in neonates (2 to 16 ml min-1 kg-1).ConclusionsLarge inter-individual variation was seen in morphine clearance values in critically ill neonates and infants.Electronic supplementary materialThe online version of this article (doi:10.1007/s00228-015-1843-x) contains supplementary material, which is available to authorized users.

Monitoring of micturition and bladder volumes can replace routine indwelling urinary catheters in children receiving intravenous opioids: a prospective cohort study

“…The large number of critically ill patients included in this study could in part explain these results. It is known that critically ill children may have reduced physiological clearance of opioids due to impaired hepatic and/or renal function [ 23 , 24 ]. In addition, encouragement of spontaneous voiding may not always be possible in sedated patients.…”

Opioid response in paediatric cancer patients and the Val158Met polymorphism of the human catechol-O-methyltransferase (COMT) gene: an Italian study on 87 cancer children and a systematic review

“…For example, children younger than 11 years show faster clearance of morphine and morphine metabolites than older subjects [37]. Furthermore, there is wide variability in morphine clearance among paediatric subjects, particularly neonates and infants [38].…”

Current knowledge, challenges and innovations in developmental pharmacology: A combined conect4children Expert Group and European Society for Developmental, Perinatal and Paediatric Pharmacology White Paper

“…A meta‐analysis reported moderate (2‐fold) to high (10‐fold) interindividual variability in morphine clearance (and in relative M6G levels) depending on the paediatric age group, but especially in critically ill patients. 88 Moreover, the highest interpatient variability in dose–exposure relationship was observed in neonates and infants. Specifically in neonates morphine elimination is driven by hepatic maturation, while renal maturation determines its glucuronides excretion.…”

“…The PK‐related effect of morphine in neonates and children thus depends not only on ontogeny of the morphine elimination process, but also on specific ontogeny profiles of M6G formation and elimination, justifying quantification of M6G next to morphine also in paediatric morphine PK studies. A meta‐analysis reported moderate (2‐fold) to high (10‐fold) interindividual variability in morphine clearance (and in relative M6G levels) depending on the paediatric age group, but especially in critically ill patients 88 . Moreover, the highest interpatient variability in dose–exposure relationship was observed in neonates and infants.…”